[1]
Villman, K. et al. 2006. TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer. Acta Oncologica. 45, 5 (Jan. 2006), 590–596. DOI:https://doi.org/10.1080/02841860500543182.